Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Acute and subchronic effects of SR-58611A on glucose tolerance in mice

July 31, 1997

No Comments

Troglitazone approved in the U.K.

July 31, 1997

No Comments

Phase I comparison of CCKA agonist and CCK-8 for effects on satiety

July 31, 1997

No Comments

Antiobesity drug therapy

July 31, 1997

No Comments

Clinical pharmacokinetics, safety and efficacy of orlistat

July 31, 1997

No Comments

Licenses offered for cell replication technology

July 30, 1997

No Comments

FDA approves Niaspan for the treatment of mixed lipid disorders

July 30, 1997

No Comments

Research Triangle Institute investigates compounds for male fertility control

July 30, 1997

No Comments

Vivus launches new device for erectile dysfunction in the U.S.

July 29, 1997

No Comments

Papaverine/phentolamine compared to PGE1 for erectile dysfunction

July 29, 1997

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Endocrine/metabolic
RSS

Acute and subchronic effects of SR-58611A on glucose tolerance in mice

Troglitazone approved in the U.K.

Phase I comparison of CCKA agonist and CCK-8 for effects on satiety

Antiobesity drug therapy

Clinical pharmacokinetics, safety and efficacy of orlistat

Licenses offered for cell replication technology

FDA approves Niaspan for the treatment of mixed lipid disorders

Research Triangle Institute investigates compounds for male fertility control

Vivus launches new device for erectile dysfunction in the U.S.

Papaverine/phentolamine compared to PGE1 for erectile dysfunction

Today's news in brief

Today's news in brief

Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance

Australia’s Celosia heads toward clinic with gene therapy for ALS

Sangamo stock plunges as Pfizer leaves hemophilia partnership

Endocrine/metabolic RSS

Endocrine/metabolic
RSS